Media-OutReach Newswire
Media-OutReach Newswire
clinical trial
Media-OutReach Newswire
Media-OutReach Newswire
Application for clinical trial of AIM Vaccine’s human diploid rabies vaccine
Media-OutReach Newswire
Policy Address by Hong Kong SAR’s Chief Executive John Lee: Reform for Enhancing Development and Building Our Future Together
Media-OutReach Newswire
Phase III clinical data of AIM Vaccine iterative serum-free rabies vaccine reaches preset goals
Media-OutReach Newswire
The bull market of innovative drug technology is booming, and the leading stock AIM Vaccine has erupted upward
Media-OutReach Newswire
New report by the Lung Cancer Education and Advocacy for Patients highlights role of patient advocacy in providing better care for patients
 and the School of Optometry of The Hong Kong Polytechnic University (PolyU) announced their latest collaborative initiative, ZEISS MyoCare Lenses, featuring (From left to right) Prof. Kee Chea-su, Head, School of Optometry, PolyU; Prof. Christopher Chao, Vice President (Research and Innovation), PolyU; Mr. David Ferran, Vice president, Latin Amer)
Media-OutReach Newswire
ZEISS Adopts PolyU's Patented Technology to Develop ZEISS MyoCare Myopia Control Lenses for Children
Society
Conference promotes sharing experiences in lung cancer research practices in Việt Nam
Media-OutReach Newswire
HKU AIDS Institute & Immuno Cure’s Collaborative Therapeutic HIV Vaccine Research Project secured HK$66.7m TRS funding from Research Grant Council
Media-OutReach Newswire
Immuno Cure Successfully Admitted into the HKSTP Elite Programme
Society
Clinical research contributes to the development of new cancer treatment methods
Media-OutReach Newswire
Immuno Cure’s Anti-Δ42PD1 Antibody Project Awarded HKSAR Government’s RAISe+ Scheme Funding
Media-OutReach Newswire
LiveSpo Pharma Emerges as Vietnam's Pioneer at Vitafoods Europe 2024
Media-OutReach Newswire
AIM Vaccine Announces 2023 Annual Results
Media-OutReach Newswire
Berlin Cures' BC 007 Targeting Long COVID Achieves Solid Progress with Over 50% Patient Recruitment in Phase II Trial
Media-OutReach Newswire
Berlin Cures' BC 007 Targets Long COVID: Solid Phase II Trial Progress with Over 50% Patient Recruitment
Media-OutReach Newswire
AIM Vaccine Enters the Period of Explosive Growth in Major Single Products
Media-OutReach Newswire
Poredeen Appoints ICB as Exclusive Named Patient Program Manager for HMTM# in Hong Kong and Macau
 Pierre Fabre)
Media-OutReach Newswire
A Treatment Option for Metastatic Colorectal Cancer Patients with BRAFV600E Mutation in Singapore
Media-OutReach Newswire
G-NiiB Oral Microbiome Immunity Formula SIM01 Alleviates Post-COVID-19 Conditions
E-paper
Fine arts exhibition promotes Vietnam-RoK cultural exchange, friendship
1.
Việt Nam's defence ministry honours Russian veterans
2.
Seminar seeks to boost Việt Nam – US energy, industry, trade cooperation
3.
Switzerland provides US$3.3 million to promote Việt Nam's circular economy
4.
Week celebrates great solidarity among ethnic groups – Việt Nam’s cultural heritage
5.
Party leader of Việt Nam holds phone talks with President-elect of US
1.
63% of Vietnamese consumers expected to increase spending on essential goods in 2025
2.
VN's trade turnover surges 16% in ten months
3.
Việt Nam, Chile issue joint statement
4.
Humanitarian surgery programme provides free artificial hip and knee joints for poor patients
5.
